Cargando…
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients
Lyme disease is the most common vector-borne disease in the United States, with an estimated incidence of 300,000 infections annually. Antibiotic intervention cures Lyme disease in the majority of cases; however, 10 to 20% of patients develop posttreatment Lyme disease syndrome (PTLDS), a debilitati...
Autores principales: | Morrissette, Madeleine, Pitt, Norman, González, Antonio, Strandwitz, Philip, Caboni, Mariaelena, Rebman, Alison W., Knight, Rob, D’Onofrio, Anthony, Aucott, John N., Soloski, Mark J., Lewis, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527730/ https://www.ncbi.nlm.nih.gov/pubmed/32994327 http://dx.doi.org/10.1128/mBio.02310-20 |
Ejemplares similares
-
Corrigendum to “Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data”
por: Chung, Ming Kei, et al.
Publicado: (2023) -
Contrast Sensitivity Loss in Patients With Posttreatment Lyme Disease
por: Rebman, Alison W., et al.
Publicado: (2021) -
The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome
por: Rebman, Alison W., et al.
Publicado: (2017) -
Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model
por: O’Connor, Kathleen, et al.
Publicado: (2019) -
Early Disseminated Lyme Disease with Carditis Complicated by Posttreatment Lyme Disease Syndrome
por: Novak, Cheryl, et al.
Publicado: (2017)